{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:39:41Z","timestamp":1773805181081,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1038\/eye.2017.295","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T10:42:02Z","timestamp":1515148922000},"page":"734-742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Response of central serous chorioretinopathy evaluated by multimodal retinal imaging"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2891-2012","authenticated-orcid":false,"given":"R","family":"Sacconi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Baldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Carnevali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Querques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Rabiolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Marchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Bandello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Querques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"BFeye2017295_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","volume":"115","author":"AS Kitzmann","year":"2008","unstructured":"Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP . The incidence of central serous chorioretinopathy in Olmsted County, Minnesota,1980-2002. Ophthalmology 2008; 115: 169\u2013173.","journal-title":"Ophthalmology"},{"key":"BFeye2017295_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1442-9071.2012.02847.x","volume":"41","author":"G Quin","year":"2013","unstructured":"Quin G, Liew G, Ho IV, Gillies M, Fraser-Bell S . Diagnosis and interventions for central serous chorioretinopathy: review and update. Clin Exp Ophthalmol 2013; 41: 187\u2013200.","journal-title":"Clin Exp Ophthalmol"},{"key":"BFeye2017295_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00006982-200202000-00004","volume":"22","author":"RH Loo","year":"2002","unstructured":"Loo RH, Scott IU, Flynn HW Jr, Gass JD, Murray TG, Lewis ML et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 2002; 22: 19\u201324.","journal-title":"Retina"},{"key":"BFeye2017295_CR4","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/archopht.1994.01090200063023","volume":"112","author":"DR Guyer","year":"1994","unstructured":"Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D . Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994; 112: 1057\u20131062.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2017295_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0002-9394(14)70531-8","volume":"121","author":"C Pr\u00fcnte","year":"1996","unstructured":"Pr\u00fcnte C, Flammer J . Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996; 121: 26\u201334.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2017295_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","volume":"41","author":"G Liew","year":"2013","unstructured":"Liew G, Quin G, Gillies M, Fraser-Bell S . Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol 2013; 41: 201\u2013214.","journal-title":"Clin Exp Ophthalmol"},{"key":"BFeye2017295_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/00006982-199911000-00005","volume":"19","author":"T Iida","year":"1999","unstructured":"Iida T, Kishi S, Hagimura N, Shimizu K . Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 1999; 19: 508\u2013512.","journal-title":"Retina"},{"key":"BFeye2017295_CR8","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.ophtha.2012.02.021","volume":"119","author":"P Jirarattanasopa","year":"2012","unstructured":"Jirarattanasopa P, Ooto S, Tsujikawa A, Yamashiro K, Hangai M, Hirata M et al. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. Ophthalmology 2012; 119: 1666\u20131678.","journal-title":"Ophthalmology"},{"key":"BFeye2017295_CR9","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","volume":"29","author":"Y Imamura","year":"2009","unstructured":"Imamura Y, Fujiwara T, Margolis R, Spaide RF . Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009; 29: 1469\u20131473.","journal-title":"Retina"},{"key":"BFeye2017295_CR10","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1097\/IAE.0b013e31821801c5","volume":"31","author":"SW Kim","year":"2011","unstructured":"Kim SW, Oh J, Kwon SS, Yoo J, Huh K . Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy. Retina 2011; 31: 1904\u20131911.","journal-title":"Retina"},{"key":"BFeye2017295_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","volume":"47","author":"EA Bouzas","year":"2002","unstructured":"Bouzas EA, Karadimas P, Pournaras CJ . Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002; 47: 431\u2013448.","journal-title":"Surv Ophthalmol"},{"key":"BFeye2017295_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0002-9394(99)00075-6","volume":"128","author":"MK Tittl","year":"1999","unstructured":"Tittl MK, Spaide RF, Wong D, Pilotto E, Yannuzzi LA, Fisher YL et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999; 128: 63\u201368.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2017295_CR13","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/S0161-6420(02)01117-X","volume":"109","author":"CA Carvalho-Recchia","year":"2002","unstructured":"Carvalho-Recchia CA, Yannuzzi LA, Negr\u00e3o S, Spaide RF, Freund KB, Rodriguez-Coleman H et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology 2002; 109: 1834\u20131837.","journal-title":"Ophthalmology"},{"key":"BFeye2017295_CR14","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0161-6420(02)01975-9","volume":"110","author":"R Haimovici","year":"2003","unstructured":"Haimovici R, Rumelt S, Melby J . Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 2003; 110: 698\u2013703.","journal-title":"Ophthalmology"},{"key":"BFeye2017295_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1001\/jamaophthalmol.2017.0245","volume":"135","author":"EH van Dijk","year":"2017","unstructured":"van Dijk EH, Schellevis RL, van Bergen MG, Breukink MB, Altay L, Scholz P et al. Association of a haplotype in the NR3C2 gene, encoding the mineralocorticoid receptor, with chronic central serous chorioretinopathy. JAMA Ophthalmol 2017; 135: 446\u2013451.","journal-title":"JAMA Ophthalmol"},{"key":"BFeye2017295_CR16","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1172\/JCI61427","volume":"122","author":"M Zhao","year":"2012","unstructured":"Zhao M, C\u00e9l\u00e9rier I, Bousquet E, Jeanny JC, Jonet L, Savoldelli M et al. Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 2012; 122: 2672\u20132679.","journal-title":"J Clin Invest"},{"key":"BFeye2017295_CR17","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","volume":"33","author":"E Bousquet","year":"2013","unstructured":"Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Behar-Cohen F . Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2013; 33: 2096\u20132102.","journal-title":"Retina"},{"key":"BFeye2017295_CR18","doi-asserted-by":"crossref","unstructured":"Breukink MB, den Hollander AI, Keunen JE, Boon CJ, Hoyng CB . The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy. Acta Ophthalmol 2014; e488\u2013e490.","DOI":"10.1111\/aos.12392"},{"key":"BFeye2017295_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.5301\/ejo.5000727","volume":"26","author":"C Leisser","year":"2016","unstructured":"Leisser C, Hirnschall N, Hackl C, Plasenzotti P, Findl O . Eplerenone in patients with chronic recurring central serous chorioretinopathy. Eur J Ophthalmol 2016; 26: 479\u2013484.","journal-title":"Eur J Ophthalmol"},{"key":"BFeye2017295_CR20","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2147\/OPTH.S86778","volume":"11","author":"EK Chin","year":"2015","unstructured":"Chin EK, Almeida DR, Roybal CN, Niles PI, Gehrs KM, Sohn EH et al. Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy. Clin Ophthalmol 2015; 11: 1449\u20131456.","journal-title":"Clin Ophthalmol"},{"key":"BFeye2017295_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/IAE.0000000000000748","volume":"36","author":"Q Ghadiali","year":"2016","unstructured":"Ghadiali Q, Jung JJ, Yu S, Patel SN, Yannuzzi LA . Central serous chorioretinopathy treated with mineralorticoid antagonists: a one-year pilot study. Retina 2016; 36: 611\u2013618.","journal-title":"Retina"},{"key":"BFeye2017295_CR22","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s00417-016-3373-3","volume":"254","author":"B Cakir","year":"2016","unstructured":"Cakir B, Fischer F, Ehlken C, B\u00fchler A, Stahl A, Schlunck G et al. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2016; 254: 2151\u20132157.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye2017295_CR23","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","volume":"87","author":"WM Chan","year":"2003","unstructured":"Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK . Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003; 87: 1453\u20131458.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2017295_CR24","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ophtha.2013.11.040","volume":"121","author":"JI Lim","year":"2014","unstructured":"Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Spaide RF, Macula Society CSC Collaborative Study Group. Research and Education Committee and Website Committee. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology 2014; 121: 1073\u20131078.","journal-title":"Ophthalmology"},{"key":"BFeye2017295_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/OPTH.S39584","volume":"7","author":"M Ratanasukon","year":"2013","unstructured":"Ratanasukon M, Thongthong K, Bhurayanontachai P, Jirarattanasopa P . Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy. Clin Ophthalmol 2013; 7: 87\u201392.","journal-title":"Clin Ophthalmol"},{"key":"BFeye2017295_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00006982-200602000-00027","volume":"26","author":"M Colucciello","year":"2006","unstructured":"Colucciello M . Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. Retina 2006; 26: 239\u2013242.","journal-title":"Retina"},{"key":"BFeye2017295_CR27","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.ophtha.2015.01.029","volume":"122","author":"TE De Carlo","year":"2015","unstructured":"De Carlo TE, Bonini Filho MA, Chin AT, Adhi M, Ferrara D, Baumal CR et al. Spectral-domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology 2015; 122: 1228\u20131238.","journal-title":"Ophthalmology"},{"key":"BFeye2017295_CR28","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1097\/IAE.0000000000000766","volume":"35","author":"GJ Coscas","year":"2015","unstructured":"Coscas GJ, Lupidi M, Coscas F, Cagini C, Souied EH . Optical coherence tomography angiography versus traditional multimodal imaging in assessing the activity of exudative age-related macular degeneration: a new diagnostic challenge. Retina 2015; 35: 2219\u20132228.","journal-title":"Retina"},{"key":"BFeye2017295_CR29","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1097\/IAE.0000000000000834","volume":"35","author":"A Miere","year":"2015","unstructured":"Miere A, Querques G, Semoun O, El Ameen A, Capuano V, Souied EH . Optical coherence tomography angiography in early type 3 neovascularization. Retina 2015; 35: 2236\u20132241.","journal-title":"Retina"},{"key":"BFeye2017295_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/IAE.0b013e3181c72068","volume":"30","author":"A Tsujikawa","year":"2010","unstructured":"Tsujikawa A, Ojima Y, Yamashiro K, Ooto S, Tamura H, Nakagawa S et al. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography. Retina 2010; 30: 801\u2013809.","journal-title":"Retina"},{"key":"BFeye2017295_CR31","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.ajo.2014.08.010","volume":"158","author":"SJ Park","year":"2014","unstructured":"Park SJ, Kim BH, Park KH, Woo SJ . Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy. Am J Ophthalmol 2014; 158: 1155\u20131163.","journal-title":"Am J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2017295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2017295","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/eye.2017.295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/eye2017295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:32:22Z","timestamp":1684431142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2017295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["BFeye2017295"],"URL":"https:\/\/doi.org\/10.1038\/eye.2017.295","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,5]]},"assertion":[{"value":"9 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}